This chapter examines the current struggles of Dexcom, a leader in continuous glucose monitoring for diabetes care, following a recent stock decline. It highlights key challenges such as a sales team realignment and competitive pressures from rivals like Abbott and Medtronic. Despite these obstacles, the chapter emphasizes Dexcom's significant growth potential and market opportunities within an expanding diabetes device market.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode